企业家上书省领导诉苦——自主创新药为何进不了医保目录

Why innovative drugs cannot be enrolled by the medical insurance directory?

“孙副省长，最近我们在山东碰到一件很不可思议、也很难理解的事：正在进行的通过政府采购将部分医保目录外抗肿瘤靶向药纳入山东省职工大病保险和居民大病保险补偿范围的项目遴选中，入围的全是进口药，

Ding Lieming, the chairman of Betta Pharmaceuticals, wrote several letters to the goverment oi cials of Shan Dong province. In those letters, he expressed his concern about why Conmana, an innovative anticancer drug invited by Betta, was not enrolled by the medical insurance directory. Drugs that have been enrolled in the directory are all exported from abroad. Many other chinese pharmaceutical companies have the same concern. Why chinese innovative drugs cannot be enrolled by the medical insurance directory? In the article, CEW journalist tries to give an answer to the question.